Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Press Releases

Read current and past press releases outlining the latest news and announcements from The Lustgarten Foundaiton.

2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018

2010 Press Releases

Record-breaking $1.7 million raised at Holiday Rock & Roll Bash to benefit The Lustgarten Foundation
Cablevision Systems Corporation (NYSE: CVC), Rainbow Media,Cablevision’s programming subsidiary, and Madison Square Garden (Nasdaq: MSG) presented the tenth annual HolidayRock & Roll Bash on Thursday, December 9, to benefit The Lustgarten Foundation. The event raised $1.7 million -- themost money raised ever in a single night in New York City for scientific and clinical research related to the diagnosis,treatment and cure of pancreatic cancer. With Cablevision’s multi-year commitment to underwrite all of The LustgartenFoundation’s administrative costs, every dollar of the $1.7 million raised goes directly to pancreatic cancer research. Read More...

Lustgarten Foundation and Cablevision Announce Year-One Results of curePC Campaign

As part of a multi-year commitment to The Lustgarten Foundation, Cablevision has engaged all of its media and entertainment assets on behalf of curePC. Those assets range from cable television systems to print publications and Web sites to movie theatres and entertainment venues. Read More...

The Lustgarten Foundation Forms National Pancreatic Cancer Research Consortium
The Lustgarten Foundation announced today that it has formed a national pancreatic cancer research consortium, a collaborative effort involving six world-renowned medical institutions to advance the most promising research initiatives aimed at finding a cure for pancreatic cancer. Read More...

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265


2015 website development and design sponsored by Celgene